Onconetix, Inc. (ONCO)
0.656
+0.01
(+0.85%)
USD |
NASDAQ |
Aug 24, 16:00
0.6575
0.00 (0.00%)
After-Hours: 07:16
Onconetix Total Assets (Quarterly) : 16.43M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.43M |
| March 31, 2026 | 14.83M |
| December 31, 2025 | 24.94M |
| September 30, 2025 | 19.68M |
| June 30, 2025 | 19.12M |
| March 31, 2025 | 18.78M |
| December 31, 2024 | 28.46M |
| September 30, 2024 | 61.92M |
| June 30, 2024 | 59.46M |
| March 31, 2024 | 75.03M |
| December 31, 2023 | 88.82M |
| September 30, 2023 | 27.88M |
| Date | Value |
|---|---|
| June 30, 2023 | 29.75M |
| March 31, 2023 | 22.50M |
| December 31, 2022 | 26.31M |
| September 30, 2022 | 30.16M |
| June 30, 2022 | 23.63M |
| March 31, 2022 | 19.34M |
| December 31, 2021 | 3.085M |
| September 30, 2021 | 3.422M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 4.812M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Aprea Therapeutics, Inc. | 42.29M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.956M |
| Shareholders Equity (Quarterly) | 13.47M |
| Debt to Equity Ratio | 0.0139 |
| Current Ratio | 2.214 |
| Net Debt Paydown Yield | 45.08% |